More Articles

Novartis introduces branded generic tacrolimus Generics/News | Posted 06/04/2012

Novartis announced on 3 April 2012 that it had launched a branded generic version of Astellas Pharma’s immunosuppressant Prograf (tacrolimus).

BIO and GPhA support biosimilar and generic user fees Biosimilars/General | Posted 06/04/2012

Both the Biotechnology Industry Organization (BIO) and the Generic Pharmaceutical Association (GPhA) have expressed their support of user fees for biosimilars and generics.

Also noted on generics: 6 April 2012 Generics/General | Posted 06/04/2012

Tropsium XR patents declared invalidWatson Pharmaceuticals confirmed in early April 2012 that the United States District Court for the District of Delaware has ruled that four patents for Sanctura...

Also noted on pharma: 6 April 2012 Pharma News | Posted 06/04/2012

MPs concerned over medicines shortages in UKNineteen UK Ministers of Parliament (MP) have now signed a Parliamentary motion demanding that the government holds ‘urgent discussions’ on the selling...

AstraZeneca losing fight against generic quetiapine Generics/News | Posted 06/04/2012

AstraZeneca’s is losing the fight it seems to protect its blockbuster antipsychotic drug Seroquel (quetiapine fumarate).

Also noted on biosimilars: 6 April 2012 Biosimilars/General | Posted 06/04/2012

Amgen and AstraZeneca make monoclonal antibody dealBiotech giant Amgen and pharma major AstraZeneca announced on 2 April 2012 an agreement to jointly develop and commercialise five monoclonal anti...

Canada drug shortages Pharma News | Posted 30/03/2012

Sandoz, the generics unit of pharma giant Novartis, is at the centre of Canadian drug shortages, however, the company is assuring Canadians that it will not raise prices of drugs sourced from overs...

Attitudes towards prescribing generics in Malaysia Generics/Research | Posted 30/03/2012

A recent study carried out in Malaysia has shown that pharmacists in the country have a lack of confidence in generic medicines produced by local pharmaceutical companies [1].